We have been very impressed with MQS product and commercial achievements so far, and sincerely believe that the team and their quantum chemistry simulation platform will disrupt the drug formulation space. We think the company stands out from the competition and has a clear value proposition for accelerating the pharma R&D pipeline.
The pharmaceutical and biopharmaceutical industries typically invest between approximately 20 and 60 billion USD in drug formulation and manufacturing upscaling phases. With the tools developed by Molecular Quantum Solutions, users can now screen and evaluate new materials for applications such as batteries, green solvents, pharmaceutical drugs, and biodegradable plastics without the need for expensive laboratory experiments.
%201.png)
